肾移植后妊娠:急性排斥与子痫前期的鉴别
该回顾性病例对照注册研究纳入1968至2019年国际移植妊娠注册中至少20周单胎妊娠的成年肾移植受者,比较26例活检证实的急性排斥与78例子痫前期患者。急性排斥者围产期血肌酐升高更常见(73% vs 14%),子痫前期者蛋白尿较基线显著增加;急性排斥与更高的32周前分娩及移植肾丢失风险相关。
要点
- 围产期血肌酐升高(73% vs 14%)更支持急性排斥而非子痫前期。
- 蛋白尿较基线显著增加仅见于子痫前期患者。
- 急性排斥者32周前分娩率53% vs 20%,校正后aOR 4.04(95%CI 1.10-15.2)。
核心结论
- 妊娠期急性排斥与更高血肌酐水平相关,子痫前期与蛋白尿增加相关。
- 急性排斥给肾移植受者带来的早产和移植肾丢失风险超过子痫前期。
研究设计与样本
- 回顾性病例对照注册研究,数据来自国际移植妊娠注册1968至2019年分娩记录。
- 纳入至少20周单胎妊娠的成年肾移植受者,26例活检证实的急性排斥按受孕年份匹配78例子痫前期。
主要发现
- 急性排斥组围产期血肌酐升高者占73%,子痫前期组占14%(P<.001)。
- 产时血肌酐中位数急性排斥组3.90 mg/dL,子痫前期组1.15 mg/dL(P<.001)。
- 蛋白尿较基线显著增加仅见于子痫前期患者。
- 急性排斥组32周前分娩率53%,子痫前期组20%。
- 急性排斥组2年内移植肾丢失42% vs 10%,长期丢失73% vs 35%(P均<.001)。
关键数值与推荐
- 急性排斥为活检证实,子痫前期依据当代标准诊断。
- 控制高血压和免疫抑制剂使用后,急性排斥与32周前分娩相关(校正OR 4.04,95%CI 1.10-15.2)。
临床怎么用
- 肾移植受者妊娠期出现血肌酐升高应警惕急性排斥,蛋白尿显著增加更提示子痫前期。
- 急性排斥者需关注早产及移植肾丢失风险,产后应加强肾功能随访。
局限性
- 回顾性注册研究设计,样本量较小(急性排斥26例)。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the clinical and laboratory characteristics in pregnancy that differentiate preeclampsia from acute renal allograft rejection and to investigate the maternal, neonatal, and graft sequelae of these diagnoses. METHODS: We conducted a retrospective case-controlled registry study of data abstracted from Transplant Pregnancy Registry International deliveries between 1968 and 2019. All adult kidney transplant recipients with singleton pregnancies of at least 20 weeks of gestation were included. Acute rejection was biopsy proven and preeclampsia was diagnosed based on contemporary criteria. Variables were compared using χ2, Fisher exact, and Wilcoxon rank sum tests as appropriate. Multivariable linear regression was used to analyze preterm birth. Kaplan-Meier curves with log-rank test and Cox proportional hazards model were used to compare graft loss over time. RESULTS: There were 26 pregnant women with biopsy-confirmed acute rejection who were matched by the year they conceived to 78 pregnant women with preeclampsia. Recipients with acute rejection had elevated peripartum serum creatinine levels (73% vs 14%, P<.001), with median intrapartum creatinine of 3.90 compared with 1.15 mg/dL (P<.001). Conversely, only patients with preeclampsia had a significant increase in proteinuria from baseline. Although there were no significant differences in maternal outcomes, graft loss within 2 years postpartum (42% vs 10%) and long-term graft loss (73% vs 35%) were significantly increased in recipients who experienced acute rejection (P<.001 for both). The frequency of delivery before 32 weeks of gestation was 53% with acute rejection and 20% with preeclampsia. After controlling for hypertension and immunosuppressant use, acute rejection was associated with higher frequency of delivery at less than 32 weeks of gestation (adjusted odds ratio 4.04, 95% CI 1.10-15.2). CONCLUSION: In pregnancy, acute rejection is associated with higher creatinine levels, and preeclampsia is associated with increased proteinuria. Acute rejection in pregnancy carries a risk of prematurity and graft loss beyond that of preeclampsia for kidney transplant recipients. FUNDING SOURCE: The Transplant Pregnancy Registry International is supported in part by an educational grant from Veloxis Pharmaceuticals.
引用
- Yin O, Kallapur A, Coscia L, et al. Differentiating Acute Rejection From Preeclampsia After Kidney Transplantation. Obstet Gynecol. 2021. PMID: 33957644. doi:10.1097/AOG.0000000000004389
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。